Supply of radiopharmaceutical FLUORDOPA (18F) for positron emission tomography
Original notice title
Czechia – Radio-isotopes – Dodávky radiofarmaka FLUORDOPA (18F) pro pozitronovou emisní tomografii.
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
30 / 100
Risk factors
Structured data indicates no framework agreement, but description mentions 'rámcové dohody'. XML notice shows no contra...
Procurement documents were not analyzed; only the TED notice is available. Required documents, eligibility, and technic...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 6.6M estimated value
- Supplies contract
- 1 lot
- Duration 24 MONTH
- Supply of radiopharmaceutical FLUORDOPA (18F) for PET tomography.
- Continuous partial deliveries over 24 months.
Show full summary
Open tender by Fakultní nemocnice Motol a Homolka for the supply of radiopharmaceutical FLUORDOPA (18F) for PET tomography at the Homolka site. The contract is for 24 months with a single lot, estimated value 6,635,000 CZK. Award is based solely on lowest price. Electronic submission is required. The tender has a 35-day deadline from publication. Inconsistencies exist regarding framework agreement status and EU funding.
Risks
Structured data indicates no framework agreement, but description mentions 'rámcové dohody'. XML notice shows no contra...
Procurement documents were not analyzed; only the TED notice is available. Required documents, eligibility, and technic...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure.
Administrative
- Electronic submission mandatory.
- Tender must be submitted in Czech language (CES).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Praha - Motol, CZE
Website
Buyer profile
Identifier
00064203
Activity
Health
Lots (1)
LOT-0001
Supply of radiopharmaceutical FLUORDOPA (18F) for positron emission tomography
Continuous partial deliveries of FLUORDOPA (18F) for PET center at Homolka for 24 months from framework agreement effectiveness.
EUR 273.6k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Jako nejvýhodnější bude hodnocena nabídka s nejnižší nabídkovou cenou pro účely hodnocení.
Additional CPV codes
Value note
Show original TED data
Original lot title
Dodávky radiofarmaka FLUORDOPA (18F) pro pozitronovou emisní tomografii.
Original TED description
Předmětem plnění této veřejné zakázky je zabezpečení průběžných dílčích dodávek radiofarmaka FLUORDOPA (18F) pro pozitronovou emisní tomografii pro PET centrum pracoviště Homolka, a to po dobu 24 měsíců ode dne nabytí účinnosti rámcové dohody mezi zadavatelem a dodavatelem.
Procurement Details
- Publication date
- 09 Jul 2026
- Languages
- Czech
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 478765-2026
Documents (1)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
30 / 100
Risk factors
Structured data indicates no framework agreement, but description mentions 'rámcové dohody'. XML notice shows no contra...
Procurement documents were not analyzed; only the TED notice is available. Required documents, eligibility, and technic...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications